Добірка наукової літератури з теми "Poliomyelitis – Vaccination"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Poliomyelitis – Vaccination".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Poliomyelitis – Vaccination"
Chamberlain, R. "Poliomyelitis vaccination." BMJ 295, no. 6591 (July 18, 1987): 158–59. http://dx.doi.org/10.1136/bmj.295.6591.158.
Повний текст джерелаMelnick, Joseph L. "Poliomyelitis Vaccination." Clinical Immunotherapeutics 6, no. 1 (July 1996): 1–6. http://dx.doi.org/10.1007/bf03259348.
Повний текст джерелаLanghorst, Silvan Elias, Niklas Frahm, Michael Hecker, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Felicita Heidler, and Uwe Klaus Zettl. "Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis." Journal of Personalized Medicine 12, no. 5 (April 23, 2022): 677. http://dx.doi.org/10.3390/jpm12050677.
Повний текст джерелаTian, Maoqiang, Jing Yang, Lei Li, Juan Li, Wenting Lei, and Xiaomei Shu. "Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review." Current Pharmaceutical Design 25, no. 43 (January 9, 2020): 4570–78. http://dx.doi.org/10.2174/1381612825666191119095132.
Повний текст джерелаMaltezou, Helena C., Christos Rahiotis, Maria Tseroni, Phoebus Madianos, and Ioannis Tzoutzas. "Attitudes toward Vaccinations and Vaccination Coverage Rates among Dental Students in Greece." International Journal of Environmental Research and Public Health 19, no. 5 (March 1, 2022): 2879. http://dx.doi.org/10.3390/ijerph19052879.
Повний текст джерелаArnold, Jana Nele, Nils Gundlach, Irina Böckelmann, and Stefan Sammito. "Impfstatus von jungen Arbeitnehmern – Eine Erhebung bei Berufsanfängern der Bundeswehr." ASU Arbeitsmedizin Sozialmedizin Umweltmedizin 2020, no. 12 (November 27, 2020): 770–75. http://dx.doi.org/10.17147/asu-2012-8715.
Повний текст джерелаGreco, Donato, Lucia Fiore, Alexander Sallabanda, and Heleni Diamanti. "Poliomyelitis vaccination strategies for Europe." Lancet 349, no. 9049 (February 1997): 437. http://dx.doi.org/10.1016/s0140-6736(97)80066-9.
Повний текст джерелаWassilak, Steven GF, George P. Oblapenko, Sieghart Dittmann, R. Bruce Aylward, and Harry F. Hull. "Poliomyelitis vaccination strategies for Europe." Lancet 349, no. 9049 (February 1997): 437. http://dx.doi.org/10.1016/s0140-6736(05)65063-5.
Повний текст джерелаSlater, Paul E. "Poliomyelitis vaccination: the essential booster." Vaccine 9, no. 7 (July 1991): 527. http://dx.doi.org/10.1016/0264-410x(91)90049-c.
Повний текст джерелаvan Wijhe, M., A. D. Tulen, H. Korthals Altes, S. A. McDonald, H. E. de Melker, M. J. Postma, and J. Wallinga. "Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands." Epidemiology and Infection 146, no. 6 (March 14, 2018): 716–22. http://dx.doi.org/10.1017/s0950268818000481.
Повний текст джерелаДисертації з теми "Poliomyelitis – Vaccination"
Трунова, Інна Олександрівна, Инна Александровна Трунова, Inna Oleksandrivna Trunova та Б. В. Липівець. "Проблема вакцинації в Україні". Thesis, Сумський державний університет, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45395.
Повний текст джерелаГоляр, О. І., та А. В. Панчошак. "Проблема імунопрофілактики поліомієліту в Україні". Thesis, Сумський державний університет, 2016. http://essuir.sumdu.edu.ua/handle/123456789/45385.
Повний текст джерелаOliveira, Thairiane Guimarães. "Completude e atraso da vacinação contra poliomielite antes e após a substituição da vacina oral pela injetável." Universidade Federal de Goiás, 2018. http://repositorio.bc.ufg.br/tede/handle/tede/8703.
Повний текст джерелаApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2018-07-17T13:45:37Z (GMT) No. of bitstreams: 2 Dissertação - Thairiane Guimarães Oliveira - 2018.pdf: 3935527 bytes, checksum: b2d64a8b08632bbd37415a47356f6a37 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)
Made available in DSpace on 2018-07-17T13:45:37Z (GMT). No. of bitstreams: 2 Dissertação - Thairiane Guimarães Oliveira - 2018.pdf: 3935527 bytes, checksum: b2d64a8b08632bbd37415a47356f6a37 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2018-05-23
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
INTRODUCTION: The oral polio vaccine (OPV) can cause a vaccine-derived poliovirus, which is a deterrent to the complete eradication of the disease. Globally, there is a gradual replacement of OPV by the poliomyelitis vaccine (VIP). Brazil has adopted an IPV-OPV mixed schedule since 2012, but no study was conducted to evaluate and compare the completeness and delay of vaccinations before and after the replacement of the oral vaccination with the inactivated poliovirus vaccination. OBJECTIVES: To compare the completion and delay of vaccination of children under 12 months of age before and after the introduction of the VIP vaccine in routine vaccination. METHODOLOGY: Before-and-after study with two live birth cohorts in the city of Goiânia, Goiás. A cohort of live births in 2010 received the vaccine regimen exclusively with OPV, and another cohort of live births in 2014 received the mixed vaccine regimen IPV-OPV. Two sources of nominal secondary data were used: the Ambulatory Care Control System, which contains data on vaccines and the Live Birth Information System, which contains data on the child and the mother. Completeness of vaccination schedule was defined as the receipt of three valid doses from the primary series up to 12 months of age. Vaccination delay was defined as the dose of vaccine given >28 days after the recommended age. The SICAA and SINASC databases were linked by deterministic linkage to identify the records of the same child. The follow-up time for each child was 12 months. RESULTS: A total of 23,335 children were included, 9,563 of the cohort born in 2010 and 13,772 of the cohort born in 2014. The proportion of children who received the IPV-OPV mixed regimen presented 78.0% of vaccine completeness, while the proportion of children who received only OPV schedule presented 72.4% of vaccine completeness (p=0.000). A higher proportion of vaccine delay of the 1st dose was observed: 6.9% and 5.8%, the second dose was 25.4% and 18.2%, and the third dose was 31.1% and 19.3% for the IPV-OPV and exclusively VOP vaccination schemes, respectively. Children who received the IPV-OPV mixed schedule had a highest median age at all doses, more days of delay and longer intervals between doses, when compared to children who received the OPV schedule. CONCLUSION: Children who received the VIP-VOP mixed schedule presented higher vaccine delay, but a greater proportion of vaccine completeness when compared to the children who received only OPV schedule. Efforts to achieve at-risk groups with delays are still needed despite improvements in the completeness of polio vaccines.
INTRODUÇÃO: A vacina oral contra poliomielite (VOP) pode provocar uma poliovirose derivada da vacina, o que constitui um empecilho à completa erradicação da doença. Mundialmente, está ocorrendo uma substituição gradual da VOP pela vacina injetável contra poliomielite (VIP). O Brasil adotou um esquema misto VIP-VOP desde 2012, mas nenhum estudo foi realizado para avaliar e comparar a completude e atraso aos esquemas antes e após a substituição da vacinação oral pela injetável. OBJETIVOS: Comparar a completude e o atraso vacinal de crianças menores de doze meses de idade antes e após a introdução da vacina VIP na vacinação de rotina. METODOLOGIA: Estudo tipo antes-e-depois da introdução da vacina injetável contra poliomielite, com duas coortes de nascidos vivos no município de Goiânia, Goiás. Uma coorte de nascidos vivos em 2010 recebeu o esquema vacinal exclusivamente com VOP e, outra coorte de nascidos vivos em 2014 recebeu o esquema vacinal misto VIP-VOP. Foram utilizadas duas fontes de dados secundários nominais: o do Sistema de Controle do Atendimento Ambulatorial (SICAA) que contém dados de vacinas e o Sistema de Informação de Nascidos Vivos (SINASC) que contém dados sobre a criança e a mãe. Completude do esquema vacinal foi definido como o recebimento de três doses válidas da série primária até os 12 meses de idade. Atraso vacinal foi definido como a dose de vacina administrada >28 dias após a idade recomendada. As bases de dados SICAA e SINASC foram vinculadas por meio de linkage determinístico para identificação dos registros de mesma criança. O tempo de seguimento de cada criança foi de 12 meses. RESULTADOS: Foram incluídas 23.335 crianças, sendo 9.563 da coorte de nascidos em 2010 e 13.772 da coorte de nascidos em 2014. A proporção de crianças que recebeu o esquema misto VIP-VOP apresentou 78,0% de completude vacinal, enquanto que a proporção de crianças que recebeu o esquema exclusivamente VOP apresentou 72,4% de completude vacinal (p=0.000). Ainda se observou maior proporção de atraso vacinal da 1º dose: 6,9% e 5,8%, 2° dose: 25,4% e 18,2% e, 3° dose: 31,1% e 19,3% para os esquemas vacinais VIP-VOP e exclusivamente VOP, respectivamente. As crianças que receberam o esquema misto VIP-VOP apresentaram maior mediana da idade em todas as doses, mais dias de atraso e maiores intervalos entre as doses, quando comparado com as crianças que receberam o esquema exclusivamente VOP. CONCLUSÃO: Crianças que receberam o esquema misto VIP-VOP apresentaram maior atraso vacinal, mas maior proporção de completude vacinal quando comparadas com as crianças que receberam o esquema exclusivamente VOP. Apesar de melhorias alcançadas na completude das vacinas contra a poliomielite, ainda são necessários esforços para atingir grupos de risco com atrasos.
Mahamat, Nadjib Abderahim Saleh. "Evaluation des connaissances et des comportements des parents sur la vaccination contre la poliomyélite : enquête dans les ménages en zones urbaines et périurbaines de la ville d'Abéché à l'Est du Tchad." Thesis, Tours, 2018. http://www.theses.fr/2018TOUR3305/document.
Повний текст джерелаThe aim of this thesis was to identify the brakes and levers for poliomyelitis eradication strategies in developing countries and then to analyze through a questionnaire the knowledge, attitudes and practices vis-à-vis poliomyelitis vaccination for parents of children aged 0-5 in Chad. A review of the literature was conducted by cross-referencing the PubMed database with keywords and a limitation of articles published between 2010-2015 in English and French to identify the barriers and levers to polio vaccination and then a survey to was conducted to relatives in the town of Abeche. The most cited barriers were the refusal of vaccination, insecurity and armed conflict, making access difficult for children and promoting the circulation of poliovirus. Many countries have taken steps to improve immunization coverage. The survey of 210 parents revealed that no family had a vaccination record of their children. However, 97% reported having children who participated in mass vaccination campaigns. Nearly 97% knew about polio and 98% had heard about vaccination campaigns. This work has identified several brakes and levers for the eradication of poliomyelitis. In Chad, knowledge of the disease and the vaccine is good despite rumors about the side effects of vaccines. Nevertheless, the lack of vaccination cards limited the analysis of the results of the survey, only declarative with a very high vaccination rate reported
WEISS, HUBERT. "Vers l'eradication de la poliomyelite en l'an 2000 ?" Université Louis Pasteur (Strasbourg) (1971-2008), 1993. http://www.theses.fr/1993STR1M185.
Повний текст джерелаPERROTEAU, FRANCOISE. "A propos de trois cas de poliomyelite anterieure aigue en haute-vienne." Limoges, 1988. http://www.theses.fr/1988LIMO0214.
Повний текст джерелаFraipont, Florence de. "Caractérisation et utilisation des déterminants phénotypiques et moléculaires de la neurovirulence et de l'atténuation des souches de poliovirus." Strasbourg 1, 1992. http://www.theses.fr/1992STR15085.
Повний текст джерелаGEORGESCU, MARIA-MAGDALENA. "Determinants moleculaires viraux impliques dans l'etiologie et la pathogenese de la poliomyelite paralytique associee a la vaccination." Paris 6, 1996. http://www.theses.fr/1996PA066160.
Повний текст джерелаAmiell, Serge. "Tétanos, poliomyélite et diphtérie : étude du statut vaccinal de l'adulte et de la réponse immunitaire en fonction de l'âge à 3 types de vaccins." Bordeaux 2, 1990. http://www.theses.fr/1990BOR25099.
Повний текст джерелаКниги з теми "Poliomyelitis – Vaccination"
Smith, Jane S. Patenting the sun: Polio and the Salk vaccine. New York: W. Morrow, 1990.
Знайти повний текст джерелаPolio eradication and its discontents: An historian's journey through an international public health (un)civil war. New Delhi: Orient Blackswan, 2012.
Знайти повний текст джерелаA tale of two drops. New Delhi: Ocean Books, 2005.
Знайти повний текст джерелаWorld Health Organization. Regional Office for Africa. Progress report on the Polio Eradication Initiative in the African region, 1996/97. Belvedere, Harare, Zimbabwe: The Office, 1998.
Знайти повний текст джерелаWest Bengal Board of Madrasah Education. Polio-Cell. Polio documentation. Kolkata: West Bengal Board of Madrasah Education, 2004.
Знайти повний текст джерелаThe Cutter incident: How America's first polio vaccine led to today's growing vaccine crisis. New Haven, CT: Yale University Press, 2005.
Знайти повний текст джерелаOffit, Paul A. The Cutter incident: How America's first polio vaccine led to the growing vaccine crisis. New Haven, CT: Yale University Press, 2005.
Знайти повний текст джерелаPolio. New York: Cavendish Square, 2015.
Знайти повний текст джерелаGouverneur polio: Le Rotary sur les rives du Congo. Paris: L'Harmattan, 2011.
Знайти повний текст джерелаVeliquette, Norman. Fulfilling our promise: Rotarians volunteer in Gujarat, India. Traverse City, Mich: The War on Polio Fund, 2004.
Знайти повний текст джерелаЧастини книг з теми "Poliomyelitis – Vaccination"
Christenson, B. "Mass vaccination programme aimed at eradication of measles in Sweden." In Measles and Poliomyelitis, 37–45. Vienna: Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-9278-8_4.
Повний текст джерелаOldstone, Michael B. A. "Poliomyelitis." In Viruses, Plagues, and History, 151–86. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190056780.003.0007.
Повний текст джерелаTizard, Ian R., and Jeffrey M. B. Musser. "Poliomyelitis—1841: The triumph of vaccination." In Great American Diseases, 215–34. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-323-98925-1.00001-5.
Повний текст джерелаWilliam Tong, C. Y. "Vaccine-Preventable Diseases." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0024.
Повний текст джерелаMillward, Gareth. "Poliomyelitis." In Vaccinating Britain. Manchester University Press, 2019. http://dx.doi.org/10.7765/9781526126764.00010.
Повний текст джерелаSmallman-Raynor, Matthew, Andrew Cliff, Keith Ord, and Peter Haggett. "Infectious Disease Control." In A Geography of Infection, 135–54. Oxford University Press, 2022. http://dx.doi.org/10.1093/oso/9780192848390.003.0006.
Повний текст джерелаЗвіти організацій з теми "Poliomyelitis – Vaccination"
Hakeem, Luqman, and Riaz Hussain. Key Considerations: Localisation of Polio Vaccination Efforts in the Newly Merged Districts (Tribal Areas) of Pakistan. SSHAP, September 2022. http://dx.doi.org/10.19088/sshap.2022.035.
Повний текст джерела